Skip To Content
PHW236A: Regulatory Science, Drug Development, and Public Health is a Course

PHW236A: Regulatory Science, Drug Development, and Public Health

Oct 25 - Dec 19, 2021
3.0 credits

Spots remaining: 10

$1,200 Enroll

Full course description

This interdisciplinary regulatory science course brings together participants working in regulatory agencies, public health, law, medicine, business, and policy to gain an understanding of the most prominent product regulation issues in the US and abroad. Innovation is needed to address the 21st century’s evolving regulatory landscape, in the context of new technologies, new understanding of diseases, and a sharpened lens on safety. This new exciting area of science requires a new generation of trained regulatory experts and professionals in academic, government, industry, and public health sectors. Building regulatory capacity is important for the US as well as for the rest of the world. Aiming to address this demand for increased training, the course provides the information needed to understand the most important health practice and product regulation issues in the US and abroad from the perspective of current regulatory standards, their standards for evidence, and the role of innovation in regulatory science. The course features networking opportunities with experts from regulatory agencies, biotech, and the pharmaceutical industry. These guest lecturers will discuss the ongoing need for interaction between government, academia, industry, and the public.

Instructor: Veronica Miller

Course Cost: $400/unit

Course Credit: Certificate of Completion issued by UC Berkeley's School of Public Health

Cancellation Policy: Written cancellation notification must be emailed to sph_catalog@berkeley.edu prior to the start date of the class in which you are registered in order to qualify for a refund, less a 5% administrative fee.